Cyprus/Greece/MaltaCyprusGreeceMalta

Athens expands national ban on GM maize varieties

16.05.2007

Athens – Greek Deputy Agriculture Minister Alexandros Kontos has renewed a decree banning the sale of genetically engineered Mon810 Bt maize varieties for another 18 months after an ultimatum of the European Commission ran out in January. In mid-April, his ministry extended this market ban to additional 16 transgenic maize varieties that entered the Common ‘EU Seed Catalogue of Varieties of Agricultural Plant Species’ last year.
Greece fears negative long-term ecological effects such as the development of insect resistance, the disruption of biodiversity among non-harmful and beneficial insects, and a heightened danger of GM cross-pollination due to “the high prevalence of bee-keeping in Greece and the relatively small size of holdings”. The Greek move is based on the so-called safeguard clause, that allows EU member states to implement precautionary measures if they provide scientific evidence for adverse effects on human and animal health or on the environment caused by transgenic crops.
Last summer, the European Food Safety Authority (EFSA) evaluated scientific data presented by the Greek government. However, the EFSA concluded that there was no evidence for any negative impact of the transgenic crops that could justify a national ban on Mon810 acreage. On the basis of this safety assessment, the Commission asked Greece to lift the ban on acreage of the 17 authorized Mon810 varieties.
The Commission is under pressure to push the member states to follow the EU decisions on GM varieties. Otherwise it has to face financial consequences due to market protectionism. In 2006, the World Trade Organisation (WTO) concluded that there was no scientific evidence for a EU GM moratorium from 1998 to 2003 and demanded the Commission lift the existing GM market bans.
The GM-sceptical environmental group Greenpeace applauded Greece’s decision to renew and to extend its ban on the sale and cultivation of genetically-modified maize seeds.

Cyprus/Greece/MaltaCyprusGreeceMalta

10.12.2011

Athens – Greek researchers have called on members of the international research community to sensitise their governments to the problems in their country’s research landscape. “The orderly execution of the badly needed reforms...

Cyprus/Greece/MaltaCyprusGreeceMalta

01.10.2011

Athens – The supply of innovative bio­pharmaceuticals to Greek hospitals has broken down. Swiss Roche AG has pulled the plug by stopping delivery of drugs for cancer and other diseases to some state-funded hospitals. Among them...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.06.2011

Athens – The situation in the pharmaceutical market in Greece increasingly looks to be spiralling out of control. According to the Financial Times, the Greek government already appears to be unable to pay healthcare companies...

Cyprus/Greece/MaltaCyprusGreeceMalta

10.07.2010

Athens – The Novo Nordisk Group has restarted sales of its insulin products in Greece. At the beginning of June, the Danish pharmaceutical company had pulled out 17 products – mostly insulin or insulin analogues – after the Greek...

Cyprus/Greece/MaltaCyprusGreeceMalta

11.03.2010

Athens – A EUR2.5m EU research project targeting olfaction in the malaria carrier Anopheles gambiae is to be coordinated by Greek researchers from the Institute of Bio­logy at the Demokritos National Centre of Scientific Research...

Cyprus/Greece/Malta, PolandCyprusGreeceMalta

29.04.2009

Nicosia – Golgi Pharmaceuticals Ltd is strengthening its collaboration with London-based ReGen Therapeutics. The Cypriot firm will produce and package Colostrinin tablets, and expand distribution to Greece and other Balkan...

Cyprus/Greece/MaltaCyprusGreeceMalta

29.04.2009

Athens –The 5th International Biotechnology Forum (IGBF5), which is to be held May 8-9 in Athens, boasts appearances by three Nobel Prize winners. Andrew Schally, Richard Roberts and Sir Peter Mansfield will speak at the opening...

Cyprus/Greece/MaltaCyprusGreeceMalta

16.04.2009

Golgi Pharmaceuticals of Cyprus is strengthening its collaboration with London-based ReGen Therapeutics. Golgi will produce tablets of and package Colostrinin, and expand distribution to Greece and other Balcan countries....

Cyprus/Greece/MaltaCyprusGreeceMalta

03.11.2008

Athens/Houston – Greece is planning to establish state-of-the-art clinics for stem cell therapy with associated stem cell banks. In mid-August, GloCal Investment Ventures Enterprise (G.I.V.E.) – a venture capital fund backed by...

Cyprus/Greece/MaltaCyprusGreeceMalta

18.08.2008

Athens – Greek diagnostics supplier Neo­medica has entered into a distribution agreement with Swedish Life Assays AB (Lund), a daughter of Chemel AB. Neo­medica, a specialist for point-of care tests, now has exclusive rights to...

Displaying results 1 to 10 out of 47

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-cyprus-greece-malta/article/athens-expands-national-ban-on-gm-maize-varieties.html

Product of the week

Products

Events

All Events

Current issue

All issues